PODD— INSULET CORP

Health Care$10.0B mkt cap

Metric	FY2025	FY2024	FY2023	FY2022
Revenue	$2.71B+30.7%	$2.07B+22.1%	$1.70B+30.0%	$1.31B
Cost of revenue	$768.2M+22.7%	$625.9M+16.5%	$537.2M+7.5%	$499.7M
Gross profit	$1.94B+34.2%	$1.45B+24.6%	$1.16B+44.0%	$805.6M
Research and development expenses	$301.1M+37.1%	$219.6M+7.1%	$205.0M+13.8%	$180.2M
Selling, general and administrative expenses	$1.17B+27.0%	$917.2M+24.8%	$734.8M+25.0%	$587.8M
Operating income	$473.8M+53.4%	$308.9M+40.3%	$220.1M+485.4%	$37.6M
Interest expense, net of portion capitalized (Note 8)	-$59.4M-39.1%	-$42.7M-18.0%	-$36.2M-0.6%	-$36.0M
Interest income	$34.7M-12.2%	$39.5M+38.1%	$28.6M+207.5%	$9.3M
Loss on extinguishment of debt	-$123.9M	$0	$0	—
Other income (expense), net	$14.3M+360.0%	-$5.5M-350.0%	$2.2M+300.0%	-$1.1M
Income before income taxes	$339.5M+13.1%	$300.2M+39.8%	$214.7M+2090.8%	$9.8M
Income tax (expense) benefit	-$92.4M-178.2%	$118.1M+1522.9%	-$8.3M-59.6%	-$5.2M
Net income	$247.1M-40.9%	$418.3M+102.8%	$206.3M+4384.8%	$4.6M
Basic (in dollars per share)	$3510000.00-41.2%	$5970000.00+101.7%	$2960000.00+4128.6%	$70000.00
Diluted (in dollars per share)	$3480000.00-39.8%	$5780000.00+96.6%	$2940000.00+4100.0%	$70000.00
Basic (in shares)	70.35B+0.4%	70.08B+0.5%	69.75B+0.5%	69.38B
Diluted (in shares)	71.89B-2.7%	73.89B+0.4%	73.63B+5.3%	69.91B
Nonrelated Party
Related Party

Source: SEC EDGAR XBRL. % change vs prior period shown where available.

Pro feature

Unlock 13 more years of annual history and full quarterly detail on Pro.

Source: SEC EDGAR 10-K and 10-Q filings. Last 4 years annual and quarterly free, full history (up to 20 years) on Pro.